X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (15) 15
male (10) 10
female (9) 9
aged (8) 8
oncology (8) 8
aged, 80 and over (7) 7
animals (7) 7
article (7) 7
middle aged (7) 7
hematology (6) 6
leukemia (6) 6
mice (6) 6
sulfonamides - administration & dosage (6) 6
acute myeloid-leukemia (5) 5
adult (5) 5
biochemistry & molecular biology (5) 5
bridged bicyclo compounds, heterocyclic - administration & dosage (5) 5
cancer therapies (5) 5
cell biology (5) 5
leukemia, lymphocytic, chronic, b-cell - drug therapy (5) 5
proto-oncogene proteins c-bcl-2 - antagonists & inhibitors (5) 5
sulfonamides - adverse effects (5) 5
abt-199 (4) 4
administration, oral (4) 4
analysis (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
bridged bicyclo compounds, heterocyclic - adverse effects (4) 4
cll (4) 4
disease-free survival (4) 4
intensive chemotherapy (4) 4
leukemia, lymphocytic, chronic, b-cell - pathology (4) 4
abridged index medicus (3) 3
antineoplastic agents - administration & dosage (3) 3
apoptosis (3) 3
care and treatment (3) 3
chronic lymphocytic-leukemia (3) 3
expression (3) 3
gene expression (3) 3
gene-expression (3) 3
hemic and lymphatic diseases (3) 3
histone deacetylases - metabolism (3) 3
nuclear proteins - metabolism (3) 3
older patients (3) 3
open-label (3) 3
proteins (3) 3
proto-oncogene proteins c-bcl-2 - metabolism (3) 3
studies (3) 3
sulfonamides - therapeutic use (3) 3
survival rate (3) 3
treatment outcome (3) 3
acute myelogenous leukemia (2) 2
adp-ribose polymerase (2) 2
aniline compounds - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bcl-2 (2) 2
bcl-2 inhibition (2) 2
benzimidazoles - adverse effects (2) 2
binding sites (2) 2
biomarkers (2) 2
cancer (2) 2
cells, cultured (2) 2
cellular biology (2) 2
chemotherapy (2) 2
chromosome deletion (2) 2
chromosomes, human, pair 17 - genetics (2) 2
chronic lymphatic leukemia (2) 2
chronic lymphocytic leukemia (2) 2
clinical trials and observations (2) 2
dacarbazine - adverse effects (2) 2
dacarbazine - analogs & derivatives (2) 2
development and progression (2) 2
diseases (2) 2
dna repair (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
eto protein (2) 2
follow-up studies (2) 2
gene deletion (2) 2
gene regulatory networks - drug effects (2) 2
hdac3 (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cells - cytology (2) 2
histone deacetylase inhibitors (2) 2
inhibitor (2) 2
leukemia, lymphocytic, chronic, b-cell - genetics (2) 2
leukemia, lymphocytic, chronic, b-cell - metabolism (2) 2
leukemia, lymphocytic, chronic, b-cell - mortality (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
leukemia, myeloid, acute - pathology (2) 2
lymphoma (2) 2
lymphomas (2) 2
maximum tolerated dose (2) 2
medical prognosis (2) 2
mice, knockout (2) 2
multicenter (2) 2
mutation (2) 2
mutations (2) 2
n-cor (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 768 - 778
Journal Article
The Lancet Oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 216 - 228
Elderly patients (aged ≥65 years) with acute myeloid leukaemia have poor outcomes and no effective standard-of-care therapy exists. Treatment with... 
INTENSIVE CHEMOTHERAPY | BCL-2 INHIBITION | OLDER PATIENTS | ONCOLOGY | ABT-199 | CARE | Antimitotic agents | Aged patients | Antineoplastic agents | Analysis
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 65 - 75
Journal Article
The EMBO Journal, ISSN 0261-4189, 04/2008, Volume 27, Issue 7, pp. 1017 - 1028
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 10/2014, Volume 32, Issue 5, pp. 904 - 912
Journal Article
Journal Article
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 09/2017, Volume 92, Issue 5, pp. 331 - 339
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1709 - 1709
Abstract Background: We recently reported encouraging antileukemic activity of venetoclax, an orally available selective BCL-2 inhibitor, in combination with... 
Journal Article